DEF 14AThe Ballot
BIOCRYST PHARMACEUTICALS INC files DEF 14A
Filed Apr 23, 2026 · 2mo ago · Accession 0001628280-26-026822
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- DEF 14A
- Filing date
- Apr 23, 2026
- Report date
- Jun 11, 2026
- Document
- bcrx-20260423.htm
- Size
- 3.5 MB